The effect of levetiracetam (Keppra) on the treatment of tremor in multiple sclerosis.

Trial Profile

The effect of levetiracetam (Keppra) on the treatment of tremor in multiple sclerosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top